JPTs Diabetes Peptide%3b GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits
PFAS chemicals, known for their persistence in the environment and links to adverse health effects, have spurred international legal actions, new research, and community responses
Yan Wu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
[200] [78] [201] In locus coeruleus norepinephrine neurons, TAAR1-dependent RhoA signaling promotes EAAT3 internalization and subsequent glutamate reuptake inhibition
Hepatic histomorphology and TG content detection showed that GSTM2 KO mice had higher hepatic fat content (Fig
Biosimilar Approvals, by Product Type, 2015 to 2025 Exhibit 259: Physician Perceptions of Biosimilars, by Specialty, 2023 Exhibit 260: Formulary Coverage for Humira and Its Biosimilars, by PBM, 2025 Exhibit 261: Formulary Coverage and Pricing for Stelara and Its Biosimilars, by PBM, 2026 Exhibit 262: Top Specialty Therapy Categories, Generic Drugs as a Share of Prescriptions and Net Spending, 2025 Exhibit 263: Nonbiological Specialty Drugs, Pharmacy Acquisition Cost per Unit for Brand-Name vs
